Immunocore
IMCR
$58.46
Share price
0.79%
Change (1 day)
-1.88%
Change (1 year)
Categories
P/S ratio for Immunocore (IMCR)
P/S ratio as of April 2024 (TTM): 9.36
According to Immunocore's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.35577. At the end of 2023 the company had a P/S ratio of 10.8.
P/S ratio history for Immunocore from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.8 | -31.79% |
| 2022 | 15.8 | -61.87% |
| 2021 | 41.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |